The new patents, US Patent Nos. 11,020,387 and 11,020,388, expire in September 2032. Orexo will now have nine patents listed in the Orange Book relating to ZUBSOLV®.

Nikolaj Sørensen, President and CEO, said: "I am pleased that the USPTO continues to recognize the uniqueness of the technology behind ZUBSOLV® by granting two new patents that further strengthen the patent portfolio for ZUBSOLV®. Comprehensive patent protection is an important cornerstone to maintaining ZUBSOLV's strong profit contribution and ensuring its growth over time – one of our key objectives for the company´s overall long-term growth."